COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis. (January 2021)

• Record Type: Journal Article
• Authors: Barone, Mark Thomaz Ugliara; Ngongo, Belinda; Harnik, Simone Bega; Oliveira, Lucas Xavier de; Végh, Dániel; de Luca, Patrícia Vieira; Pedrosa, Hermelinda Cordeiro; Giraudo, Franco; Cardona-Hernandez, Roque; Chaudhury, Nayanjeet; Menna-Barreto, Luiz
• Is Part Of: Diabetes research and clinical practice. Volume 171(2021)
• Publication Date: 2021-01
• Subjects: COVID-19 -- Coronavirus -- Diabetes -- Global health -- Noncommunicable diseases -- Health systems; ADA American Diabetes Association -- ADJ (ADJ Diabetes Brasil) Brazilian Diabetes Association -- APDP Portuguese Diabetes Association -- AST Aspartate Aminotransferase -- BG Blood Glucose (glycemia) -- CHW Community Health Workers -- CRP C-Reactive Protein -- CVD Cardiovascular Disease -- DKA Diabetic Ketoacidosis -- eGFR Estimated Glomerular Filtration Rate -- HbA1c Glycated Hemoglobin A1C -- HCP Healthcare Professional -- HIC High Income Countries -- IDF International Diabetes Federation -- JDRF Juvenile Diabetes Research Foundation -- KAP-WHO Knowledge Action Portal, World Health Organization -- LMIC Low- and Middle-Income Countries -- NCD noncommunicable disease -- OSA Obstructive Sleep Apnea -- PAHO Pan American Health Organization -- PHC Primary Health Care -- PwD People with Diabetes -- SACA South and Central America -- SARS Acute Respiratory Syndrome -- SBD Brazilian Diabetes Society -- T1D Type 1 Diabetes mellitus -- T2D Type 2 Diabetes mellitus -- UHC Universal Health Coverage; Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2020.108587
• Languages: English
• ISSNs: 0168-8227

Abstract

Abstract: COVID-19 has gravely threatened high-risk populations, such as people with diabetes and other noncommunicable diseases, leading to disproportionate hospitalizations and deaths worldwide. It is well documented from previous outbreaks that diabetes increases the risk for poor outcomes due to SARS infection. In the present review, we bring evidence that the country and global level health crisis caused by COVID-19 could have been avoided or extremely minimized if measures to protect high-risk populations were implemented timely. In addition to general lockdowns, testing, tracing, isolation and hygiene measures, other specific interventions for diabetes and comorbidities management were shown crucial to allow the continuation of care services during the pandemic. These interventions included: teleconsultation, digital remote education andmonitoring, e-prescriptions, medicine delivery options, mobile clinics, and home point-of-care tests. In conclusion, we recommend prompt actions to protect the most vulnerable groups, valuing knowledge and experiences from previous outbreaks and lessons learned during the COVID-19 pandemic, in order to shield communities, health systems and the global economy.